ATE459346T1 - Stabile pulververabreichungsform zur inhalation - Google Patents

Stabile pulververabreichungsform zur inhalation

Info

Publication number
ATE459346T1
ATE459346T1 AT02732063T AT02732063T ATE459346T1 AT E459346 T1 ATE459346 T1 AT E459346T1 AT 02732063 T AT02732063 T AT 02732063T AT 02732063 T AT02732063 T AT 02732063T AT E459346 T1 ATE459346 T1 AT E459346T1
Authority
AT
Austria
Prior art keywords
inhalation
administration form
stable powder
powder administration
drug
Prior art date
Application number
AT02732063T
Other languages
English (en)
Inventor
Frank M Etzler
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of ATE459346T1 publication Critical patent/ATE459346T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT02732063T 2001-06-20 2002-06-11 Stabile pulververabreichungsform zur inhalation ATE459346T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/885,349 US6482429B1 (en) 2001-06-20 2001-06-20 Stable powder inhalation dosage formulation
PCT/US2002/018406 WO2003000240A2 (en) 2001-06-20 2002-06-11 Stable powder inhalation dosage formulation

Publications (1)

Publication Number Publication Date
ATE459346T1 true ATE459346T1 (de) 2010-03-15

Family

ID=25386707

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02732063T ATE459346T1 (de) 2001-06-20 2002-06-11 Stabile pulververabreichungsform zur inhalation

Country Status (9)

Country Link
US (1) US6482429B1 (de)
EP (1) EP1401409B1 (de)
JP (1) JP4348179B2 (de)
AT (1) ATE459346T1 (de)
CA (1) CA2446221C (de)
DE (1) DE60235544D1 (de)
ES (1) ES2339751T3 (de)
MX (1) MXPA03011517A (de)
WO (1) WO2003000240A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9408499D0 (en) 1994-04-28 1994-06-22 Edwin Shirley Trucking Limited A releasable joint for joining two construction elements of a transportable stage assembly
IL149984A0 (en) * 2000-10-12 2002-12-01 Boehringer Ingelheim Pharma Novel tiotropium-containing inhalation powder
US6620438B2 (en) * 2001-03-08 2003-09-16 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions based on anticholinergics and NK1-receptor antagonists
US7776315B2 (en) * 2000-10-31 2010-08-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and additional active ingredients
US20020193392A1 (en) * 2000-11-13 2002-12-19 Christel Schmelzer Pharmaceutical compositions based on tiotropium salts of salts of salmeterol
US20100310477A1 (en) * 2000-11-28 2010-12-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg. Pharmaceutical compositions based on anticholingerics and additional active ingredients
US20030070679A1 (en) * 2001-06-01 2003-04-17 Boehringer Ingelheim Pharma Kg Capsules containing inhalable tiotropium
DE10141377A1 (de) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Aufstreuverfahren zur Herstellung von Pulverformulierungen
US6919325B2 (en) * 2001-09-14 2005-07-19 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts
US7309707B2 (en) * 2002-03-20 2007-12-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
EP1494648B1 (de) * 2002-04-04 2006-09-20 Boehringer Ingelheim Pharma GmbH & Co.KG Pulverzubereitungen zur inhalation
US7763280B2 (en) * 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
WO2005049449A1 (en) * 2003-11-18 2005-06-02 Yansong Shan Healthy pleasurable inhalation device
US20050153946A1 (en) * 2003-12-24 2005-07-14 Collegium Pharmaceuticals, Inc. Temperature-stable formulations, and methods of development thereof
US8349365B2 (en) * 2005-09-27 2013-01-08 Asahi Kasei Chemicals Corporation Cellooligosaccharide-containing composition
WO2008021451A2 (en) * 2006-08-14 2008-02-21 Aktiv-Dry Llc Human-powered dry powder inhaler and dry powder inhaler compositions
TR201007250A2 (tr) * 2010-09-01 2012-03-21 Bi̇lgi̇ç Mahmut Selobioz içeren formülasyon.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302777D0 (sv) * 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
US5846516A (en) * 1992-06-03 1998-12-08 Alliance Pharmaceutial Corp. Perfluoroalkylated amphiphilic phosphorus compounds: preparation and biomedical applications
SE9203743D0 (sv) * 1992-12-11 1992-12-11 Astra Ab Efficient use
US5612053A (en) * 1995-04-07 1997-03-18 Edward Mendell Co., Inc. Controlled release insufflation carrier for medicaments
WO2002015880A2 (en) * 2000-08-25 2002-02-28 Merck Patent Gmbh Powdered mannitol and mannitol-containing compositions

Also Published As

Publication number Publication date
JP4348179B2 (ja) 2009-10-21
EP1401409B1 (de) 2010-03-03
DE60235544D1 (de) 2010-04-15
WO2003000240A2 (en) 2003-01-03
CA2446221A1 (en) 2003-01-03
CA2446221C (en) 2011-04-12
US6482429B1 (en) 2002-11-19
WO2003000240A3 (en) 2003-03-06
EP1401409A2 (de) 2004-03-31
MXPA03011517A (es) 2004-03-18
JP2004534813A (ja) 2004-11-18
ES2339751T3 (es) 2010-05-25

Similar Documents

Publication Publication Date Title
ATE459346T1 (de) Stabile pulververabreichungsform zur inhalation
WO2003026559A3 (en) Nasal nebulizer
DE60115255D1 (de) Inhalator
MXPA04003465A (es) Tratamiento de enfermedades hiperproliferativas, con el uso de analogos activos de la vitamina d.
ATE342053T1 (de) Formulierungen zur inhalation
AU2002316820A1 (en) Powder inhaler formulations
IL157771A0 (en) Intravaginal drug delivery devices for the administration of an antimicrobial agent
MXPA04004173A (es) Formas orales de liberacion controlada utiles para la reduccion o prevencion de la ansiedad hacia la nicotina.
MXPA04003668A (es) Inhibidores de fosfodiesteresa de tipo 4 y usos de los mismos.
IS7043A (is) Lyfjagjöf efnafræðilega umbreytts insúlíns í lungu
EA200401019A1 (ru) Дозированная лекарственная форма для перорального применения, содержащая ингибитор pde 4 в качестве действующего вещества и поливинилпирролидон в качестве вспомогательного вещества
PL370889A1 (en) Vaginal delivery of drugs
ATE420762T1 (de) Systeme, verfahren und geräte zur herstellung von dosierungsformen
BE2011C028I2 (en) Macrocyclic analogs and methods of their use and preparation
TNSN05046A1 (en) Method of preparing dry powder inhalation compositions
WO2002069945A3 (de) Neue arzneimittelkompositionen auf der basis von anticholinergika und pde-iv-inhibitoren
HUP0001339A2 (hu) Aeroszol gyógyszerkészítmény
WO2002043700A3 (en) Particles for use in a pharmaceutical composition
DE60202477D1 (de) Vorrichtung zur verabreichung einer substanz
WO2002036135A3 (en) Compositions for antitumour treatment containing ecteinascidin 743
EP1295609A4 (de) Medikamente mit gemischten aktiven stoffen
BR0302834A (pt) Anel sincronizador de divisões múltiplas de um conjunto sincronizador
MXPA03005980A (es) Composiciones para administracion nasal de insulina.
AU2002346143A1 (en) Compositions for nasal administration of insulin
WO2004056347A3 (en) Pharmaceutical compositions comprising insulin and legends of insulin hexamer

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1401409

Country of ref document: EP